Administration, Congress go to bat for Big Pharma

(Huffington Post) The Obama administration and members of Congress are pressing India to curb its generic medication industry. The move comes at the behest of U.S. pharmaceutical companies, which have drowned out warnings from public health experts that inexpensive drugs from India are essential to providing life-saving treatments around the world.

Low-cost generics from India have dramatically lowered medical costs in developing countries and proved critical to global AIDS relief programs; about 98 percent of the drugs purchased by President George W. Bush’s landmark PEPFAR AIDS relief program are generics from India. Before Indian companies rolled out generic versions priced at $ 1 a day, AIDS medication cost about $ 10,000 per person per year.

But India’s generic industry has also cut into profits for Pfizer and other U.S. and European drug companies. In response, these companies have sought to impose aggressive patenting and intellectual property standards in India, measures that would grant the firms monopoly pricing power over new drugs and lock out generics producers.

WND

Share

Leave a Reply

You must be logged in to post a comment.

2016 Obama’s America
USA Debt
national debt
free shipping 120x60
Archives
Uccupy Unmasked
Categories
HOPE & CHANGE
I Hope you will Spare Some Change

2nd Amendment
A well regulated Militia, being necessary to the security of a free State, the right of the people to keep and bear Arms, shall not be infringed.